Biological markers to predict previous alcohol withdrawal seizures: a risk assessment T. HillemacherH. FrielingS. Bleich OriginalPaper 10 August 2006 Pages: 151 - 154
Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test X.-Y. CuiX. ZhaoY.-H. Zhang OriginalPaper 01 August 2006 Pages: 155 - 160
Identification of an excitatory amino acid-mediated component of the ventral tegmental area local field potential response to medial prefrontal cortex stimulation: effect of acute d-amphetamine E. J. DommettJ. SimpsonP. G. Overton OriginalPaper 08 August 2006 Pages: 161 - 172
In vivo neurochemical characterization of Anatoxin-a evoked dopamine release from striatum F. CamposR. DuránM. Alfonso OriginalPaper 08 August 2006 Pages: 173 - 184
Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens A. Del ArcoF. MoraK. Fuxe OriginalPaper 08 August 2006 Pages: 185 - 193
Postnatal iron overload destroys NA-DA functional interactions A. FredrikssonT. Archer OriginalPaper 24 August 2006 Pages: 195 - 203
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice M. B. H. YoudimE. GrünblattS. Mandel OriginalPaper 01 June 2006 Pages: 205 - 209
Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease M. StacyR. Hauser OriginalPaper 10 August 2006 Pages: 211 - 217
Rotigotine transdermal system for perioperative administration A. D. KorczynH. ReichmannH.-J. Häck OriginalPaper 21 December 2006 Pages: 219 - 221
TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortex A. KorchounovT. V. IlićU. Ziemann OriginalPaper 01 August 2006 Pages: 223 - 229
The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease O. V. ForlenzaE. L. SchaefferW. F. Gattaz Review 27 November 2006 Pages: 231 - 238
Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia A. SchmittM. FendtF. A. Henn OriginalPaper 23 October 2006 Pages: 239 - 248
No association between the genetic polymorphisms in the RTN4R gene and schizophrenia in the Chinese population J. MengY. ShiL. He OriginalPaper 10 August 2006 Pages: 249 - 254
Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia S. NumataS. UenoT. Ohmori OriginalPaper 08 August 2006 Pages: 255 - 259
Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression S. WeisI. C. LlenosR. H. Yolken OriginalPaper 10 August 2006 Pages: 261 - 271
Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents C. FleischhakerP. HeiserA. Warnke OriginalPaper 17 November 2006 Pages: 273 - 280
Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone K. SchwartzI. HermanM. Rehavi OriginalPaper 20 July 2006 Pages: 281 - 284
Contralateral prefrontal projections in gerbils mature abnormally after early methamphetamine trauma and isolated rearing A. V. WitteF. BagordaK. Lehmann Short Communication 24 May 2006 Pages: 285 - 288
Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism M. ZeegersJ. van der GrondH. van Engeland OriginalPaper 24 May 2006 Pages: 289 - 295